Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

AGEN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $893,492.60

Insider Selling (Last 12 Months): $0.00

Agenus Insider Trading History Chart

Agenus Share Price & Price History

^$6.50

▼ -1.65 (-20.25%)

As of 04/15/2024 01:00 AM ET

Days: 30 | 90 | 365

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

From InvestorPlace | Ad

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

And you could go along for the ride if you make this one simple move.

Agenus Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/15/2024	Garo H. Armen	Insider	Buy	25,000	$13.00	$325,000.00	31,298
10/16/2023	Agenus Inc	Major Shareholder	Buy	21	$22.00	$462.00	1,088,643
10/12/2023	Agenus Inc	Major Shareholder	Buy	158	$22.00	$3,476.00	1,087,653
10/4/2023	Agenus Inc	Major Shareholder	Buy	750	$21.80	$16,350.00	1,087,494
8/28/2023	Agenus Inc	Major Shareholder	Buy	640	$29.00	$18,560.00	1,085,260
8/24/2023	Agenus Inc	Major Shareholder	Buy	8,512	$30.80	$262,169.60	1,084,620
5/10/2023	Agenus Inc	Major Shareholder	Buy	1,103	$30.20	$33,310.60	1,080,855
5/5/2023	Agenus Inc	Major Shareholder	Buy	5,010	$19.00	$95,190.00	1,079,752
5/3/2023	Agenus Inc	Major Shareholder	Buy	6,434	$21.60	$138,974.40	1,073,668
1/6/2022	Steven J. O'Day	Insider	Sell	1,933	$61.20	$118,299.60
10/19/2021	Agenus Inc	Major Shareholder	Buy	70,000	$240.00	$16,800,000.00
9/13/2021	Garo H. Armen	CEO	Sell	4,105	$130.00	$533,650.00	42,644
9/10/2021	Christine M. Klaskin	Insider	Sell	556	$130.00	$72,280.00

Nerd Investor Reveals Secret To Make Money With A.I.

From InvestorPlace | Ad

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

>>Check out what this A.I. Perfect Storm is<<

SEC Filings (Institutional Ownership Changes) for Agenus (NASDAQ:AGEN)

61.46% of Agenus stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Agenus Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/16/2024	Powell Investment Advisors LLC	243,500	$0.14M	0.1%	+21.8%	1.162%
4/15/2024	Key Client Fiduciary Advisors LLC	858,969	$0.50M	0.3%	+38.0%	4.100%
4/5/2024	Los Angeles Capital Management LLC	175,272	$0.10M	0.0%	-12.7%	0.042%
3/14/2024	Ables Iannone Moore & Associates Inc.	79,000	$65K	0.0%	N/A	0.020%
3/11/2024	Vanguard Group Inc.	30,266,890	$25.06M	0.0%	+12.4%	7.581%
3/1/2024	Goldman Sachs Group Inc.	2,893,617	$2.40M	0.0%	+22.8%	0.725%
2/28/2024	American International Group Inc.	189,427	$0.16M	0.0%	+8.4%	0.050%
2/26/2024	Virtu Financial LLC	257,437	$0.21M	0.0%	N/A	0.067%
2/20/2024	Readystate Asset Management LP	2,016,783	$1.67M	0.1%	+14.3%	0.505%
2/16/2024	GSA Capital Partners LLP	2,399,732	$1.99M	0.2%	+1,891.7%	0.629%
2/15/2024	Virtus ETF Advisers LLC	121,626	$0.10M	0.1%	+125.1%	0.032%
2/15/2024	Barclays PLC	610,004	$0.51M	0.0%	-32.4%	0.160%
2/15/2024	Vanguard Group Inc.	30,266,890	$25.06M	0.0%	+12.4%	7.934%
2/15/2024	Voya Investment Management LLC	292,379	$0.24M	0.0%	+102.1%	0.077%
2/15/2024	Nuveen Asset Management LLC	1,148,233	$0.95M	0.0%	+1.6%	0.301%
2/14/2024	Royal Bank of Canada	120,425	$99K	0.0%	+113.1%	0.032%
2/14/2024	Oracle Investment Management Inc.	1,416,963	$1.17M	0.7%	-33.1%	0.371%
2/14/2024	Point72 Asset Management L.P.	11,985,200	$9.92M	0.0%	-32.0%	3.142%
2/14/2024	Pennant Investors LP	469,600	$0.39M	0.1%	N/A	0.123%
2/14/2024	Putnam Investments LLC	514,617	$0.43M	0.0%	+62.7%	0.135%
2/14/2024	Shell Asset Management Co.	87,711	$73K	0.0%	N/A	0.023%
2/13/2024	Northern Trust Corp	3,482,042	$2.88M	0.0%	+4.1%	0.913%
2/13/2024	American International Group Inc.	189,427	$0.16M	0.0%	+8.4%	0.050%
2/13/2024	Tower Research Capital LLC TRC	38,820	$32K	0.0%	-69.0%	0.010%
2/13/2024	Goldman Sachs Group Inc.	2,893,617	$2.40M	0.0%	+22.8%	0.759%
2/12/2024	Crestline Management LP	708,480	$0.59M	0.0%	+6.5%	0.186%
2/12/2024	RPO LLC	51,408	$43K	0.1%	N/A	0.013%
2/9/2024	UBS Group AG	579,339	$0.48M	0.0%	-11.7%	0.152%
2/8/2024	Vanguard Personalized Indexing Management LLC	115,147	$95K	0.0%	N/A	0.030%
2/7/2024	BNP Paribas Financial Markets	103,937	$86K	0.0%	-65.1%	0.027%
2/6/2024	Charles Schwab Investment Management Inc.	2,732,853	$2.26M	0.0%	+3.9%	0.716%
2/6/2024	Los Angeles Capital Management LLC	200,812	$0.17M	0.0%	+95.3%	0.053%
2/6/2024	Swiss National Bank	635,800	$0.53M	0.0%	-7.9%	0.167%
2/1/2024	Powell Investment Advisors LLC	200,000	$0.17M	0.1%	N/A	0.052%
1/30/2024	Cardinal Strategic Wealth Guidance	910,265	$0.75M	0.3%	+28.2%	0.239%
1/30/2024	PCG Wealth Advisors LLC	47,550	$39K	0.0%	+65.7%	0.012%
1/18/2024	Values First Advisors Inc.	269,829	$0.22M	0.1%	+7.8%	0.071%
1/17/2024	Assenagon Asset Management S.A.	2,306,248	$1.91M	0.0%	+3,008.8%	0.605%
1/12/2024	SG Americas Securities LLC	198,735	$0.17M	0.0%	+526.6%	0.052%
1/9/2024	Key Client Fiduciary Advisors LLC	622,469	$0.52M	0.3%	+16.3%	0.163%
1/5/2024	Exchange Traded Concepts LLC	107,019	$89K	0.0%	+34.0%	0.028%
12/18/2023	Vanguard Group Inc.	26,938,439	$30.44M	0.0%	+1.6%	7.061%
12/6/2023	Citigroup Inc.	707,213	$0.80M	0.0%	+41.0%	0.185%
11/24/2023	Deutsche Bank AG	182,706	$0.21M	0.0%	+14.5%	0.048%
11/22/2023	Graham Capital Management L.P.	172,805	$0.20M	0.0%	-19.4%	0.045%
11/16/2023	Tudor Investment Corp Et Al	375,627	$0.42M	0.0%	-4.3%	0.099%
11/15/2023	GSA Capital Partners LLP	120,489	$0.14M	0.0%	+178.0%	0.032%
11/14/2023	Oracle Investment Management Inc.	2,116,963	$2.39M	0.7%	-30.7%	0.558%
11/14/2023	Braidwell LP	6,307,030	$7.13M	0.2%	+34.3%	1.662%
11/14/2023	Caxton Associates LP	390,234	$0.44M	0.1%	+247.3%	0.103%
11/14/2023	California State Teachers Retirement System	354,801	$0.40M	0.0%	-6.0%	0.093%
11/14/2023	Tower Research Capital LLC TRC	125,337	$0.14M	0.0%	+630.1%	0.033%
11/14/2023	Profund Advisors LLC	283,404	$0.32M	0.0%	+8.1%	0.075%
11/13/2023	Northern Trust Corp	3,345,166	$3.78M	0.0%	+1.5%	0.881%
11/13/2023	LPL Financial LLC	21,843	$25K	0.0%	-78.6%	0.006%
11/13/2023	Aigen Investment Management LP	25,307	$29K	0.0%	-54.4%	0.007%
11/13/2023	FMR LLC	452,193	$0.51M	0.0%	+43.9%	0.119%
11/13/2023	Rafferty Asset Management LLC	1,680,974	$1.90M	0.0%	+16.9%	0.443%
11/9/2023	Deutsche Bank AG	182,706	$0.21M	0.0%	+14.5%	0.048%
11/9/2023	Citigroup Inc.	707,213	$0.80M	0.0%	+41.0%	0.186%
11/9/2023	UBS Group AG	655,744	$0.74M	0.0%	-25.5%	0.173%
11/8/2023	HighTower Advisors LLC	423,855	$0.48M	0.0%	-6.2%	0.112%
11/8/2023	Charles Schwab Investment Management Inc.	2,630,559	$2.97M	0.0%	+8.4%	0.693%
11/8/2023	Swiss National Bank	690,100	$0.78M	0.0%	+5.9%	0.182%
11/8/2023	First Command Advisory Services Inc.	70,618	$80K	0.0%	N/A	0.019%
11/7/2023	Barclays PLC	902,206	$1.02M	0.0%	+16.0%	0.238%
11/7/2023	Jump Financial LLC	142,133	$0.16M	0.0%	+58.9%	0.037%
11/6/2023	Assenagon Asset Management S.A.	74,184	$84K	0.0%	-67.3%	0.020%
11/6/2023	Los Angeles Capital Management LLC	102,820	$0.12M	0.0%	-73.0%	0.027%
11/2/2023	Principal Financial Group Inc.	107,291	$0.12M	0.0%	+16.7%	0.028%
10/27/2023	Hennion & Walsh Asset Management Inc.	506,942	$0.57M	0.0%	+89.5%	0.134%
10/25/2023	Lindbrook Capital LLC	52,535	$59K	0.0%	+38.8%	0.014%
10/13/2023	SG Americas Securities LLC	31,718	$36K	0.0%	N/A	0.008%
9/21/2023	Barclays PLC	777,538	$1.24M	0.0%	-20.4%	0.205%
8/21/2023	California State Teachers Retirement System	377,441	$0.60M	0.0%	+6.5%	0.099%
8/16/2023	Nuveen Asset Management LLC	1,725,968	$2.76M	0.0%	+44.4%	0.455%
8/15/2023	Alliancebernstein L.P.	315,460	$0.51M	0.0%	+19.4%	0.083%
8/15/2023	Wells Fargo & Company MN	2,338,152	$3.74M	0.0%	+17.5%	0.616%
8/15/2023	XTX Topco Ltd	59,645	$95K	0.0%	-63.2%	0.016%
8/15/2023	Y Intercept Hong Kong Ltd	39,582	$63K	0.0%	N/A	0.010%
8/15/2023	Goldman Sachs Group Inc.	3,241,581	$5.19M	0.0%	-7.6%	0.854%
8/15/2023	Zacks Investment Management	60,000	$96K	0.0%	N/A	0.016%
8/15/2023	Captrust Financial Advisors	680,868	$1.09M	0.0%	+1.9%	0.179%
8/15/2023	Caxton Associates LP	112,371	$0.18M	0.0%	N/A	0.030%
8/15/2023	Point72 Asset Management L.P.	17,616,983	$28.19M	0.1%	+124.7%	4.641%
8/15/2023	Readystate Asset Management LP	1,764,659	$2.82M	0.2%	N/A	0.465%
8/15/2023	Royal Bank of Canada	38,540	$62K	0.0%	+124.1%	0.010%
8/15/2023	Kennedy Capital Management LLC	93,349	$0.15M	0.0%	+565.0%	0.025%
8/15/2023	Braidwell LP	4,697,930	$7.52M	0.2%	N/A	1.238%
8/14/2023	Mercer Global Advisors Inc. ADV	140,133	$0.22M	0.0%	N/A	0.037%
8/14/2023	Oracle Investment Management Inc.	3,056,460	$4.89M	3.6%	-22.5%	0.805%
8/14/2023	Ergoteles LLC	241,700	$0.39M	0.0%	N/A	0.064%
8/14/2023	Tudor Investment Corp Et Al	392,327	$0.63M	0.0%	-5.8%	0.103%
8/14/2023	Two Sigma Securities LLC	22,750	$36K	0.0%	+116.9%	0.006%
8/14/2023	Schonfeld Strategic Advisors LLC	23,172	$37K	0.0%	N/A	0.006%
8/14/2023	State of Wisconsin Investment Board	221,316	$0.35M	0.0%	-4.7%	0.058%
8/14/2023	State Street Corp	19,610,280	$31.38M	0.0%	-25.0%	5.166%
8/14/2023	Nuveen Asset Management LLC	1,725,968	$2.76M	0.0%	+44.4%	0.455%
8/14/2023	Graham Capital Management L.P.	214,362	$0.34M	0.0%	N/A	0.056%
8/11/2023	Renaissance Technologies LLC	3,425,015	$5.48M	0.0%	-23.3%	0.902%

Data available starting January 2016

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an antigen 4 (CTLA-4) blocking antibody that is in Phase 2 clinical trial for the treatment of pancreatic cancer and and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in Phase 1 clinical trial; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monospecific antibody; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract that is in a Phase 1 clinical trial; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. The company operates under Agenus, MiNK, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., Incyte Corporation, Merck Sharpe & Dohme, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $6.50

$6.43

$9.22

50 Day Range

MA: $12.36

$6.50

$18.56

52 Week Range

Now: $6.50

$6.43

$42.60

Volume

1,457,660 shs

Average Volume

483,529 shs

Market Capitalization

$136.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Who are the company insiders with the largest holdings of Agenus?: Agenus' top insider shareholders include:
Agenus Inc (Major Shareholder)
Garo H Armen (Insider)
Learn More about top insider investors at Agenus.
Who are the major institutional investors of Agenus?: Agenus' top institutional investors include:
Key Client Fiduciary Advisors LLC — 4.10%
Powell Investment Advisors LLC — 1.16%
Los Angeles Capital Management LLC — 0.04%
Learn More about top institutional investors of Agenus stock.
Which institutional investors are selling Agenus stock?: In the last quarter, AGEN stock was sold by these institutional investors:
Los Angeles Capital Management LLC
Which institutional investors are buying Agenus stock?: In the previous quarter, AGEN stock was purchased by institutional investors including:
Key Client Fiduciary Advisors LLC
Powell Investment Advisors LLC
During the last year, these company insiders have bought Agenus stock:
Agenus Inc (Major Shareholder)
Garo H Armen (Insider)
Learn More investors buying Agenus stock.

Forget Nvidia, buy this A.I. Stock Now

From InvestorPlace | Ad

Click here to see the details.

AGEN Insider Trading

Agenus Insider Trading History Chart

Agenus Share Price & Price History

Agenus Insider Trading History

SEC Filings (Institutional Ownership Changes) for Agenus (NASDAQ:AGEN)

Institutional Buying and Selling by Quarter

Agenus Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Agenus?

Who are the major institutional investors of Agenus?

Which institutional investors are selling Agenus stock?

Which institutional investors are buying Agenus stock?